Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins.
Journal: Nature communications
Published: October 22, 2025
A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.
Journal: Journal of virology
Published: May 08, 2025
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.
Journal: Journal of virology
Published: May 08, 2025
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 04, 2024
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents.
Journal: Vaccine
Published: March 18, 2024
CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice.
Journal: Vaccine
Published: May 16, 2022
Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.
Journal: The Journal of infectious diseases
Published: January 21, 2022
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
Journal: Scientific reports
Published: January 15, 2021
Last Updated: 09/26/2026